IP Library Granted Patent US 11,655,495
Granted Patent B2
US 11,655,495 · App. 17/020,516 · Granted May 23, 2023

Nucleic acid preservation solution and methods of manufacture and use

Inventor: Federico Carlos Arejola Gaeta (Torre Molinos, ES)
Assignee: Spectrum Solutions L.L.C.
C12Q1/6806C12N15/1003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,655,495
App. No.
17/020,516
Granted
May 23, 2023
Kind
B2
Abstract

Disclosed is nucleic acid preserving compositions and methods of manufacturing and using the same. Compositions include a carrier, a chaotropic agent, a buffering agent, a chelating agent, a surfactant, an alcohol, an acid, and a mucolytic agent. Compositions as aqueous solutions can include water as a carrier. Preferred embodiments include water, guanidine thiocyanate, Tris, EDTA, SLS, SDA 3C, HCl, and N-acetyl-L-cysteine. Some embodiments include a colored dye as a visual indicator. Methods of manufacturing include combining the components into a mixture, such as an aqueous solution. Methods of use include providing a biological sample that includes nucleic acid and contacting the biological sample with the composition. Kits include the composition disposed in a portion of a biological sample collection apparatus.

Claims (60)

1. A nucleic acid preservation composition, comprising:

an aqueous carrier;

about 20% to about 50%, w/w, of a chaotropic agent;

about 0.1% to about 5%, w/w, of a buffering agent;

about 0.05% to about 2.5%, w/w, of a chelating agent comprising;

about 0.01% to about 5%, w/w, of a detergent or a surfactant;

about 5% to about 25%, w/w, of an alcohol, wherein the alcohol comprises a mixture of about 95% ethanol, v/v, and about 5% isopropanol, v/v; and

0.005% to about 0.5%, w/w, of a mucolytic agent or a reducing agent, wherein the mucolytic agent or reducing agent comprises N-acetyl-L-cysteine (NAC),

the composition having a pH of 6.5-9.5.

2. The composition of claim 1 , wherein the composition has a pH of about 7 to about 9.

3. The composition of claim 1 , wherein:

the chaotropic agent comprises guanidine thiocyanate;

the buffering agent comprises tris(hydroxymethyl)aminomethane (Tris);

the chelating agent comprises ethylenediaminetetraacetic acid (EDTA) or EDTA disodium (salt) dihydrate; and

the detergent or surfactant comprises sodium lauroyl sarcosinate (SLS).

4. The composition of claim 1 , wherein the composition is substantially free or devoid of antimicrobial agent(s), bactericidal agent(s), and/or bacteriostatic agent(s) other than the chaotropic agent, the detergent or surfactant, the alcohol, and the mucolytic agent or reducing agent.

5. The composition of claim 1 , wherein the composition is substantially free or devoid of protease(s).

6. The composition of claim 1 , wherein the composition is substantially free or devoid of inhibitor(s) of ribonuclease other than the chaotropic agent, the surfactant, the alcohol, and the mucolytic agent.

7. A nucleic acid preservation kit, comprising:

a sample collection apparatus comprising a solution compartment; and

the nucleic acid preservation composition of claim 1 disposed in the solution compartment.

8. A method of preserving nucleic acid in a biological sample, the method comprising:

obtaining or providing a biological sample containing nucleic acid, the biological sample optionally comprising saliva; and

contacting the biological sample with the nucleic acid preservation composition of claim 1 .

9. A nucleic acid preservation composition, comprising:

guanidine thiocyanate;

tris(hydroxymethyl)aminomethane (Tris);

ethylenediaminetetraacetic acid (EDTA) or EDTA disodium (salt) dihydrate;

sodium lauroyl sarcosinate (SLS);

an alcohol, wherein the alcohol comprises a mixture of about 95% ethanol, v/v, and about 5% isopropanol, v/v; and

N-acetyl-L-cysteine (NAC).

10. The composition of claim 9 , wherein the composition has a pH of 6.5-9.5.

11. The composition of claim 9 , wherein the composition has a pH of about 7 to about 9.

12. The composition of claim 9 , wherein the composition is substantially free or devoid of antimicrobial agent(s), bactericidal agent(s), and/or bacteriostatic agent(s) other than the chaotropic agent, the detergent or surfactant, the alcohol, and the mucolytic agent or reducing agent.

13. The composition of claim 9 , wherein the composition is substantially free or devoid of protease(s).

14. The composition of claim 9 , wherein the composition is substantially free or devoid of inhibitor(s) of ribonuclease other than the chaotropic agent, the surfactant, the alcohol, and the mucolytic agent.

15. A nucleic acid preservation kit, comprising:

a sample collection apparatus comprising a solution compartment; and

the nucleic acid preservation composition of claim 9 disposed in the solution compartment.

16. A method of preserving nucleic acid in a biological sample, the method comprising:

obtaining or providing a biological sample containing nucleic acid, the biological sample optionally comprising saliva; and

contacting the biological sample with the nucleic acid preservation composition of claim 9 .

17. A nucleic acid preservation composition, comprising:

an aqueous carrier;

a chaotropic agent;

a buffering agent;

a chelating agent;

a detergent or a surfactant;

an alcohol, wherein the alcohol comprises a mixture of about 95% ethanol, v/v, and about 5% isopropanol, v/v; and

N-acetyl-L-cysteine (NAC).

18. The nucleic acid preservation composition of claim 17 , wherein the composition has a pH of about 7 to about 9.

19. The nucleic acid preservation composition of claim 18 , wherein:

the composition is substantially free or devoid of antimicrobial agent(s), bactericidal agent(s), and/or bacteriostatic agent(s) other than the chaotropic agent, the detergent or surfactant, the alcohol, and the mucolytic agent or reducing agent;

the composition is substantially free or devoid of protease(s); and

the composition is substantially free or devoid of inhibitor(s) of ribonuclease other than the chaotropic agent, the surfactant, the alcohol, and the mucolytic agent.

20. The nucleic acid preservation composition of claim 19 , wherein:

the chaotropic agent comprises guanidine thiocyanate;

the buffering agent comprises tris(hydroxymethyl)aminomethane (Tris);

the chelating agent comprises ethylenediaminetetraacetic acid (EDTA) or EDTA disodium (salt) dihydrate; and

the detergent or surfactant comprises sodium lauroyl sarcosinate (SLS).

Assignments (2)
SECURITY INTEREST Recorded Mar 5, 2021
From: SPECTRUM SOLUTIONS L.L.C.
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 055503/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2020
From: GAETA, FEDERICO CARLOS AREJOLA
To: SPECTRUM SOLUTIONS L.L.C.
Reel/Frame 053765/0412 →
Continuity (4)
Continuation 16176210 · Oct 31, 2018
Continuation 15872791 · Jan 16, 2018
Provisional Application 62446818 · Jan 16, 2017
Related Publication 20200407777A1 · Dec 31, 2020